Cas:634-21-9 Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide manufacturer & supplier

Chemical Name:Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide

CAS.NO:634-21-9

Synonyms:ETHYL RED IODIDE;(1-ethyl-[2]quinolyl)-(1-ethyl-[4]quinolyl)-methinium,iodide;(1-Aethyl-[2]chinolyl)-(1-aethyl-[4]chinolyl)-methinium,Jodid;1-ethyl-2-[(1-ethyl-4(1h)-quinolinylidene)methyl]-quinoliniuiodide;decynium 24;EINECS 211-205-1;isocyanine iodide;1,1′-diethyl-2,4-cyanine iodide;MFCD00051380;1-ethyl-2-[(1-ethyl-4(1H)-quinolylidene)methyl]quinolinium iodide;1-ETHYL-2-[(1-ETHYL-4(1H)-QUINOLINYLIDENE)METHYL]QUINOLINIUM IODIDE;ETHYL RED IODIDE,PURE;Ethyl Red iodide1-Ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]quinolinium iodide

Molecular Formula:C₂₃H₂₃IN₂

Molecular Weight:454.34700

HS Code:

Physical and Chemical Properties:

Melting point:158-160ºC(lit.)

Boiling point:N/A

Density:N/A

Index of Refraction:1.653

PSA:8.81000

Exact Mass:454.09100

LogP:1.23570

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2811 6.1/PG 3

Packing Group:II

Contact us for information like ETHYL RED IODIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl Red iodide1-Ethyl-2-[(1-ethyl-4(1H)-quinolinylidene)methyl]quinolinium iodide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-ETHYL-2-[(1-ETHYL-4(1H)-QUINOLINYLIDENE)METHYL]QUINOLINIUM IODIDE Use and application,1,1′-diethyl-2,4-cyanine iodide technical grade,usp/ep/jp grade.

Related News: The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.” Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide manufacturer As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured. Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide supplier Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide vendor Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. Quinaldinium, 1-ethyl-.α.-(1-ethyl-4(1H)-quinolylidene)-, iodide factory The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.”